Ignite Creation Date:
2024-05-06 @ 12:26 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03767114
Status:
COMPLETED
Last Update Posted:
2018-12-06
First Post:
2018-12-05
Brief Title:
Estimation of Level of ERAP1 Expression in Lesional and Non Lesional Skin of Psoraitic Patients and Healthy Controls
Sponsor:
Kasr El Aini Hospital
Organization:
Kasr El Aini Hospital
Study Overview
Official Title:
Estimation of Level of ERAP1 Expression in Lesional and Non Lesional Skin of Psoraitic Patients and Healthy Controls
Status:
COMPLETED
Status Verified Date:
2018-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A 4mm Punch biopsy is obtained from lesional and non lesional skin of 25 psoraitic patients as well as of 30 controls
Skin biopsy from patients psoriasis lesional and non lesional control will be kept in lysis solution which contains RNAase inhibitor for the stability of the parameter to be assessed ERAP-1 gene expression will Research Template 5 Final Version 832 016 be detected by quantitative real time -PCR which include RNA extraction cDNA synthesis PCR
Skin biopsy from patients psoriasis lesional and non lesional control will be kept in lysis solution which contains RNAase inhibitor for the stability of the parameter to be assessed ERAP-1 gene expression will Research Template 5 Final Version 832 016 be detected by quantitative real time -PCR which include RNA extraction cDNA synthesis PCR
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None